BridgeMD
New treatment option for Laparoscopic Adrenalectomy
Official title Thoracic Paravertebral Block in Daytime Laparoscopic Partial Adrenalectomy
ClinicalTrials.gov ID: NCT06566521
What this study is testing
- What it's testing
- Day surgery refers to the entire diagnostic and therapeutic process completed within 24-48 h, including patient admission, surgery, and discharge. Research by Shariq et al suggested that daytime laparoscopic adrenalectomy was a safe and effective alternative to traditional inpatient treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Aged 18 to70 years
- Body Mass Index (BMI) 18.5 to 30 kg/m²
- American Society of Anesthesiologists (ASA) grade I to II classification
- unilateral non-functional adrenal adenoma with a tumor diameter greater than 20mm
You likely can't join if
- Patients with peripheral nervous system disease
- Patients with spinal deformity or surgery
- Patients with puncture site infection or coagulation abnormalities
- Patients with history of postoperative nausea and vomiting or allergy to local anesthetics
- Patients with unstable mental illness or refusal to participate
The study team makes the final eligibility decision.
Where it's taking place
- Taiyuan, Shanxi, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taiyuan, Shanxi, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.